-
公开(公告)号:US07026326B2
公开(公告)日:2006-04-11
申请号:US10438553
申请日:2003-05-13
申请人: Guo-Qiang Cao , Celia Dominguez , Martin H. Goldberg , Fang-Tsao Hong , Kelvin K. C. Sham , Seifu Tadesse , Nuria A. Tamayo , Kurt E. Weiler , Dawei Zhang , Hongyu Liao
发明人: Guo-Qiang Cao , Celia Dominguez , Martin H. Goldberg , Fang-Tsao Hong , Kelvin K. C. Sham , Seifu Tadesse , Nuria A. Tamayo , Kurt E. Weiler , Dawei Zhang , Hongyu Liao
IPC分类号: A61K31/505
CPC分类号: C07D401/04
摘要: The present invention relates to compounds having the general formula or a pharmaceutically acceptable salt thereof, wherein R1 is a saturated or unsaturated 5-, 6- or 7-membered, ring containing 0, 1, 2 or 3 atoms selected from N, O and S, wherein the ring may be fused with a benzo group, and is substituted by 0, 1 or 2 oxo groups, and wherein R1 is additionally substituted; and R2 is a substituted C1-6alkyl. Also included is a method of prophylaxis or treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.
摘要翻译: 本发明涉及具有通式的化合物或其药学上可接受的盐,其中R 1是饱和或不饱和的5-,6-或7-元环,其含有0,1,2或 3个选自N,O和S的原子,其中环可以与苯并稠合,并被0,1或2个氧代基取代,并且其中R 1是另外被取代的; R 2是取代的C 1-6烷基。 还包括预防或治疗炎症,类风湿性关节炎,斑节病,骨质疏松症,多发性骨髓瘤,葡萄膜炎,急性或慢性骨髓性白血病,胰腺β细胞破坏,骨关节炎,类风湿性脊椎炎,痛风性关节炎,炎性肠病,成人呼吸 窘迫综合征(ARDS),牛皮癣,克罗恩病,过敏性鼻炎,溃疡性结肠炎,过敏反应,接触性皮炎,哮喘,肌肉退化,恶病质,赖特综合征,I型糖尿病,II型糖尿病,骨吸收疾病,移植物抗宿主反应, 阿尔茨海默病,中风,心肌梗死,缺血再灌注损伤,动脉粥样硬化,脑外伤,多发性硬化,脑疟疾,败血症,败血性休克,中毒性休克综合征,发热,HIV-1,HIV-2,HIV-3,巨细胞病毒引起的肌痛 (CMV),流感,腺病毒,哺乳动物中的疱疹病毒或带状疱疹感染,包括给予有效量的化合物d 以上所述。
-
公开(公告)号:US06967254B2
公开(公告)日:2005-11-22
申请号:US10658298
申请日:2003-09-08
申请人: Celia Dominguez , Dawei Zhang , Kelvin K. C. Sham , Guo-Qiang Cao
发明人: Celia Dominguez , Dawei Zhang , Kelvin K. C. Sham , Guo-Qiang Cao
IPC分类号: C07D401/04 , C07D401/14
CPC分类号: C07D401/04 , C07D401/14
摘要: The present invention relates to compounds having the general formula or a pharmaceutically acceptable salt thereof. Also included is a method of prophylaxis or treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.
摘要翻译: 本发明涉及具有通式的化合物或其药学上可接受的盐。 还包括预防或治疗炎症,类风湿性关节炎,斑节病,骨质疏松症,多发性骨髓瘤,葡萄膜炎,急性或慢性骨髓性白血病,胰腺β细胞破坏,骨关节炎,类风湿性脊椎炎,痛风性关节炎,炎性肠病,成人呼吸 窘迫综合征(ARDS),牛皮癣,克罗恩病,过敏性鼻炎,溃疡性结肠炎,过敏反应,接触性皮炎,哮喘,肌肉退化,恶病质,赖特综合征,I型糖尿病,II型糖尿病,骨吸收疾病,移植物抗宿主反应, 阿尔茨海默病,中风,心肌梗死,缺血再灌注损伤,动脉粥样硬化,脑外伤,多发性硬化,脑疟疾,败血症,败血性休克,中毒性休克综合征,发热,HIV-1,HIV-2,HIV-3,巨细胞病毒引起的肌痛 (CMV),流感,腺病毒,哺乳动物中的疱疹病毒或带状疱疹感染,包括给予有效量的化合物d 以上所述。
-
公开(公告)号:US07935709B2
公开(公告)日:2011-05-03
申请号:US11879243
申请日:2007-07-16
IPC分类号: A61K31/517
CPC分类号: C07D471/04 , C07D239/82
摘要: The present invention comprises a new class of compounds useful for the prophylaxis and treatment of pro-inflammatory cytokine mediated diseases, including inflammation and related conditions. The compounds have a general Formula I wherein s, T, R1, R2, R3 and R4 are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, methods of use such as treatment of p38 mediated diseases by administering the compounds of Formula I or compositions including the compounds of Formula I, and intermediates and processes useful for the preparation of compounds of Formula I.
摘要翻译: 本发明包括一类新的可用于预防和治疗促炎细胞因子介导的疾病,包括炎症和相关病症的化合物。 化合物具有通式I,其中s,T,R 1,R 2,R 3和R 4在本文中定义。 本发明还包括药物组合物,其包含一种或多种式I化合物,使用方法例如通过施用式I化合物或包含式I化合物的组合物治疗p38介导的疾病,以及可用于制备 式Ⅰ的化合物。
-
公开(公告)号:US07759337B2
公开(公告)日:2010-07-20
申请号:US11367123
申请日:2006-03-02
申请人: Andrew Tasker , Dawei Zhang , Guo-Qiang Cao , Partha Pratim Chakrabarti , James Richard Falsey , Bradley J. Herberich , Randall W. Hungate , Liping H. Pettus , Anthony Reed , Robert M. Rzasa , Kelvin K. C. Sham , Maya C. Thaman , Shimin Xu
发明人: Andrew Tasker , Dawei Zhang , Guo-Qiang Cao , Partha Pratim Chakrabarti , James Richard Falsey , Bradley J. Herberich , Randall W. Hungate , Liping H. Pettus , Anthony Reed , Robert M. Rzasa , Kelvin K. C. Sham , Maya C. Thaman , Shimin Xu
IPC分类号: C07D237/34 , C07D413/12 , C07D498/08 , C07D279/12 , C07D243/08 , A61K31/498 , A61K31/5355 , A61K31/537 , A61K31/541 , A61K31/551 , A61P29/00 , A61P23/00 , C07D487/04 , A61K31/4985
CPC分类号: C07D409/04 , C07D237/30 , C07D237/32 , C07D237/34 , C07D403/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/04 , C07D487/08 , C07D491/10
摘要: The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula I wherein B, R1, R2, R3, R4 and R5 are d.efined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, uses of such compounds and compositions for treatment of kinase mediated diseases including rheumatoid arthritis, psoriasis and other inflammation disorders, as well as intermediates and processes useful for the preparation of compounds of Formula I.
摘要翻译: 本发明包括一类新的可用于预防和治疗蛋白激酶介导的疾病,包括炎症和相关病症的化合物。 该化合物具有通式I,其中B,R 1,R 2,R 3,R 4和R 5在本文中定义。 本发明还包括药物组合物,其包含一种或多种式I化合物,这些化合物和组合物用于治疗激酶介导的疾病包括类风湿性关节炎,牛皮癣和其它炎症疾病的用途,以及可用于制备 一级方程式
-
公开(公告)号:US07582631B2
公开(公告)日:2009-09-01
申请号:US11034042
申请日:2005-01-11
IPC分类号: A61K31/4995 , C07D471/08 , C07D487/08
CPC分类号: C07D487/06 , C07D213/56 , C07D239/95 , C07D401/04 , C07D401/14 , C07D417/14
摘要: The present invention relates to therapeutic diazobicyclo pyridines and their use in the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis or osteoarthritis, organ transplant, acute transplant or heterograft and homograft rejection, ischemic and reperfusion injury, transplantation tolerance induction, multiple sclerosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, lupus, graft vs. host diseases, T -cell mediated hypersensitivity diseases, contact hypersensitivity, delayed-type hypersensitivity, gluten-sensitive enteropathy, Type 1 diabetes, psoriasis, contact dermatitis, Hashimoto's thyroiditis, Sjogren's syndrome, autoimmune hyperthyroidism, Graves' Disease, Addison's disease, autoimmune polyglandular disease, autoimmune alopecia, pernicious anemia, vitiligo, autoimmune hypopituatarism, Guillain-Barre syndrome, autoimmune diseases, glomerulonephritis, serum sickness, uticaria, respiratory allergies, asthma, hayfever, allergic rhinitis, skin allergies, scleracielma, mycosis fungoides, acute inflammatory responses, acute respiratory distress syndrome, dermatomyositis, alopecia areata, chronic actinic dermatitis, eczema, Behcet's disease, Pustulosis palmoplanteris, Pyoderma gangrenum, Sezary's syndrome, atopic dermatitis, systemic schlerosis, morphea, Type II diabetes and cancers where PKC theta or other PKC-family kinases are activated, overexpressed or facilitate tumor growth or survival of tumor cells, T cell leukemia, thymoma, T and B cell lymphoma, colon carcinoma, breast carcinoma and lung carcinoma or provides resistance to chemotherapeutic drugs.
摘要翻译: 本发明涉及治疗性重氮二环吡啶及其在治疗关节炎,类风湿性关节炎,银屑病关节炎或骨关节炎,器官移植,急性移植或异种移植和同种异体移植排斥,缺血和再灌注损伤,移植耐受诱导,多发性硬化,炎性肠中的用途 疾病,溃疡性结肠炎,克罗恩病,狼疮,移植物抗宿主病,T细胞介导的超敏反应性疾病,接触性超敏反应,延迟型超敏反应,麸质敏感性肠病,1型糖尿病,牛皮癣,接触性皮炎,桥本氏甲状腺炎,干燥综合征 ,自身免疫性甲状腺功能亢进症,格雷夫斯病,艾迪生病,自身免疫性多腺病,自身免疫性脱发,恶性贫血,白癜风,自身免疫性低分化症,吉兰巴利综合征,自身免疫性疾病,肾小球肾炎,血清病,荨麻疹,呼吸道过敏,哮喘,过敏性鼻炎,过敏性鼻炎 ,皮肤过敏 es,scleracielma,蕈样真菌病,急性炎症反应,急性呼吸窘迫综合征,皮肌炎,斑秃,慢性光化性皮炎,湿疹,Behcet氏病,脓疱疮,新生皮炎,Sezary综合征,特应性皮炎,全身性硬化症,morphea,II型糖尿病 和PKCθ或其他PKC家族激酶被激活,过度表达或促进肿瘤细胞,T细胞白血病,胸腺瘤,T细胞和B细胞淋巴瘤,结肠癌,乳腺癌和肺癌的肿瘤生长或存活的癌症,或提供对化学治疗的抗性 药物
-
6.
公开(公告)号:US07700593B2
公开(公告)日:2010-04-20
申请号:US11973076
申请日:2007-10-05
申请人: Dawei Zhang , Andrew Tasker , Kelvin K. C. Sham , Partha Pratim Chakrabarti , James Richard Falsey , Bradley J. Herberich , Liping H. Pettus , Robert M. Rzasa
发明人: Dawei Zhang , Andrew Tasker , Kelvin K. C. Sham , Partha Pratim Chakrabarti , James Richard Falsey , Bradley J. Herberich , Liping H. Pettus , Robert M. Rzasa
IPC分类号: A61K31/5377 , C07D221/02 , A61K31/496 , A61P29/00 , C07D295/00 , A61K31/437
CPC分类号: C07D471/04
摘要: The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula I wherein A, B, R1, R2, R3 and R4 are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, uses of such compounds and compositions for treatment of P38 map kinase mediated diseases including rheumatoid arthritis, psoriasis and other inflammation disorders, as well as intermediates and processes useful for the preparation of compounds of Formula I.
摘要翻译: 本发明包括一类新的可用于预防和治疗蛋白激酶介导的疾病,包括炎症和相关病症的化合物。 该化合物具有通式I,其中A,B,R 1,R 2,R 3和R 4在本文中定义。 本发明还包括包含一种或多种式I化合物的药物组合物,这些化合物和组合物用于治疗P38地图激酶介导的疾病(包括类风湿性关节炎,牛皮癣和其他炎症疾病)的用途,以及可用于制备 式Ⅰ的化合物。
-
公开(公告)号:US08101612B2
公开(公告)日:2012-01-24
申请号:US11899363
申请日:2007-09-04
申请人: Andrew Tasker , Dawei Zhang , Liping H. Pettus , Rob M. Rzasa , Kelvin K. C. Sham , Shimin Xu , Partha Chakrabarti
发明人: Andrew Tasker , Dawei Zhang , Liping H. Pettus , Rob M. Rzasa , Kelvin K. C. Sham , Shimin Xu , Partha Chakrabarti
IPC分类号: C07D237/30 , C07D413/04 , A61K31/502 , A61K31/5355 , A61P29/00 , A61P19/02 , A61P19/10 , A61P17/06 , A61P17/00 , A61P31/00 , A61P31/16 , A61P31/22 , A61P37/08 , A61P21/00 , A61P3/10 , A61P9/10 , A61P33/06
CPC分类号: C07D403/12 , C07D237/30 , C07D237/34 , C07D403/10 , C07D413/12 , C07D417/10 , C07D471/04
摘要: The present invention comprises a new class of compounds useful for the prophylaxis and treatment of p38 kinase mediated diseases and related inflammatory conditions. The compounds have a general Formula II wherein L1, L2, R1a, R1b, R1c, R2, R3, R3a, R4, R5 and p are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, uses of such compounds and compositions for treatment of p38 kinase mediated diseases including rheumatoid arthritis, psoriasis and other inflammation disorders, as well as intermediates and processes useful for the preparation of compounds of Formula I.
摘要翻译: 本发明包括一类新的可用于预防和治疗p38激酶介导的疾病和相关炎性病症的化合物。 该化合物具有通式II,其中本文定义了L1,L2,R1a,R1b,R1c,R2,R3,R3a,R4,R5和p。 本发明还包括包含一种或多种式I化合物的药物组合物,用于治疗p38激酶介导的疾病(包括类风湿性关节炎,牛皮癣和其它炎症疾病)的这些化合物和组合物的用途,以及可用于制备化合物的中间体和方法 的式
-
公开(公告)号:US08314131B2
公开(公告)日:2012-11-20
申请号:US12681823
申请日:2008-09-19
申请人: Liping H. Pettus , Kelvin K. C. Sham , Andrew Tasker , Shimin Xu
发明人: Liping H. Pettus , Kelvin K. C. Sham , Andrew Tasker , Shimin Xu
IPC分类号: A61K31/4192 , C07D249/06
CPC分类号: C07D249/18 , C07D401/04 , C07D403/04 , C07D403/12 , C07D409/04 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/06 , C07D417/12 , C07D471/04
摘要: The present invention comprises a new class of compounds useful for modulating the activity of p38 MAP kinase. The compounds have a general Formula I wherein A1, A2, A3, A4, A5, A6, R1 and R5 are defined herein. The invention further provides pharmaceutical compositions including one or more compounds of Formula I, use of such compounds and compositions for treatment of p38 MAP kinase mediated diseases including rheumatoid arthritis, psoriasis and other inflammatory disorders, as well as intermediates and processes useful for the preparation of compounds of Formula I.
摘要翻译: 本发明包括一类可用于调节p38 MAP激酶活性的化合物。 该化合物具有通式I,其中A1,A2,A3,A4,A5,A6,R1和R5如本文所定义。 本发明进一步提供包含一种或多种式I化合物的药物组合物,使用这些化合物和组合物用于治疗p38MAP激酶介导的疾病,包括类风湿性关节炎,牛皮癣和其它炎症性疾病,以及可用于制备 式Ⅰ的化合物。
-
公开(公告)号:US07842685B2
公开(公告)日:2010-11-30
申请号:US12456687
申请日:2009-06-18
申请人: Victor J. Cee , Michael J. Frohn , Brian Alan Lanman , Susana C. Neira , Anthony B. Reed , Kelvin K. C. Sham
发明人: Victor J. Cee , Michael J. Frohn , Brian Alan Lanman , Susana C. Neira , Anthony B. Reed , Kelvin K. C. Sham
IPC分类号: A61K31/397 , A61K31/4365 , C07D513/04
CPC分类号: C07D513/04 , A61K9/2018 , A61K9/2059 , A61K9/48
摘要: The present invention relates to compounds of Formula (I): that are have activity as S1P receptor modulating agents, more specifically to specifically compounds that are S1P1 receptor agonists. The invention also related to the use of such compounds to treat diseases associated with inappropriate S1P1 receptor activity such as autoimmune diseases.
摘要翻译: 本发明涉及式(I)化合物:其具有作为S1P受体调节剂的活性,更具体地涉及作为S1P1受体激动剂的具体化合物。 本发明还涉及使用这些化合物来治疗与不适当的S1P1受体活性相关的疾病,例如自身免疫性疾病。
-
公开(公告)号:US08952037B2
公开(公告)日:2015-02-10
申请号:US13105873
申请日:2011-05-11
申请人: Jennifer R. Allen , Michael J. Frohn , Paul E. Harrington , Essa Hu , Alexander J. Pickrell , Robert M. Rzasa , Kelvin K. C. Sham
发明人: Jennifer R. Allen , Michael J. Frohn , Paul E. Harrington , Essa Hu , Alexander J. Pickrell , Robert M. Rzasa , Kelvin K. C. Sham
IPC分类号: C07D401/12 , C07D405/14 , A61K31/4433 , A61K31/4439 , C07D471/04 , C07D401/14 , C07D403/14 , C07D413/14 , C07D417/12 , C07D417/14 , C07D487/04
CPC分类号: C07D417/14 , C07D401/14 , C07D403/14 , C07D405/14 , C07D413/14 , C07D417/12 , C07D471/04 , C07D487/04
摘要: Heteroaryloxycarbocyclyl compounds, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, Huntington's Disease, bipolar disorder, obsessive-compulsive disorder, and the like.
摘要翻译: 杂芳氧基碳环化合物和含有它们的组合物,以及制备这些化合物的方法。 本文还提供治疗通过抑制PDE10可治疗的疾病或疾病的方法,例如肥胖症,非胰岛素依赖性糖尿病,精神分裂症,亨廷顿舞蹈病,双相情感障碍,强迫症等。
-
-
-
-
-
-
-
-
-